Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumors.

Aung NaingAlain P AlgaziGerald S FalchookBenjamin C CreelanJohn PowderlySeth RosenMinal BarveNiharika B MettuPierre L TriozziJohn HammGongfu ZhouChris WalkerZhiwan DongManish R Patel

Published in: Cancer (2022)

A study of epacadostat (INCB024360) in combination with durvalumab (MEDI4736) in subjects with selected advanced solid tumors (ECHO-203) (NCT02318277).

Keyphrases

magnetic resonance
open label
randomized controlled trial
double blind